3 min read FDA Moves to End Compounded Semaglutide and Tirzepatide What It Means for Weight Loss Patients The FDA Just Proposed a Major Change to Compounded Weight Loss Drugs If you've been following the news about weight loss medications, you may have heard that the FDA announced a significant regulatory change on April 30, 2026
These shifts are usually the result of significant weight loss (which reduces the body's thyroid hormone requirement) or changes in the absorption speed of thyroid medications like levothyroxine
Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) increased 12.02% in March 2025 compared to December 2024
When Side Effects Require Medical Attention While mild nausea and changes in bathroom habits are common, it is vital to know the difference between a normal adjustment and a serious medical issue
Epub 2022 Jun 4
Many people want weight loss without feeling drained, weak or under-fuelled, but when appetite drops its easy to miss out on protein, fluids and essential nutrients